Development of a dietary supplement with antioxidant and cardioprotective action. Phase 1: Absorption and biodistribution study

Vascul Pharmacol. 2024 Jun:155:107336. doi: 10.1016/j.vph.2024.107336.
No abstract available

Publication types

  • Clinical Trial, Phase I

MeSH terms

  • Animals
  • Antioxidants* / administration & dosage
  • Antioxidants* / pharmacokinetics
  • Antioxidants* / pharmacology
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / pharmacokinetics
  • Cardiotonic Agents / pharmacology
  • Dietary Supplements*
  • Humans
  • Male
  • Tissue Distribution

Substances

  • Antioxidants
  • Cardiotonic Agents